Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

88.07

-1.42 (-1.59%)

At close: May 29, 2026, 4:00 PM EDT

87.91

-0.16 (-0.19%)

After-hours: May 29, 2026, 5:41 PM EDT

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	879	429	5	6	20	85
Market Cap Growth	228.18%	8742.00%	-18.98%	-70.74%	-75.79%	-
Enterprise Value	654	393	0	0	14	67
Last Close Price	88.07	60.66	1.17	1.60	6.15	35.71
PB Ratio	3.98	7.29	1.19	1.23	2.67	5.51
P/TBV Ratio	3.98	7.29	1.19	1.23	2.67	5.52
Debt / Equity Ratio	0	0.00	0.02	0.01	0.01	-
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.01	-1.09	-1.02
Quick Ratio	81.10	35.68	10.92	24.16	8.00	31.12
Current Ratio	81.48	36.10	11.32	24.26	8.11	31.38
Return on Equity (ROE)	-15.02%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%
Return on Assets (ROA)	-10.44%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%
Return on Capital Employed (ROCE)	-10.00%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%
Earnings Yield	-2.23%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%
Buyback Yield / Dilution	-42.99%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%

SEC Filings: 10-K · 10-Q